VNRX News and Press, VolitionRX Limited From 02/17/23

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Investors are wondering if the stock market is open on Presidents’ Day 2023 as they make weekend plans. The quick and simple answer investors are looking for is no, the stock market will not...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Ambrx Biopharma (NYSE: AMAM ) stock is falling on Friday but it’s not due to any news released by the company today. Instead, it looks like shares are retreating from a rally on Thursda...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com VolitionRX (NYSEMKT: VNRX ) stock is taking a beating on Friday after the company revealed a proposed public offering for its shares. The big news here is VolitionRX plann...

VolitionRx ( NYSE: VNRX ) priced an underwritten public offering of 4.3M shares at a public offering price of $1.75/share; underwriters granted 30-day option to purchase up to an additional 645K shares. Gross proceeds re expected to be $7.525M; net proceeds to be used fo...

VolitionRx Limited Announces Pricing of $7.525 Million Underwritten Public Offering of Common Stock PR Newswire HENDERSON, Nev. , Feb. 17, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics co...

VolitionRx ( NYSE: VNRX ) on Thursday said it has commenced an underwritten public offering of shares of its common stock. Shares -19.1% at $1.65 after hours. In addition, Volition intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the ...

Volition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporation PR Newswire HENDERSON, Nev. , Feb. 16, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition"), a multi-national epigenetics company, a...

Volition to Take Part in Nu.Q® Vet Commercial Strategy Webinar PR Newswire HENDERSON, Nev. , Jan. 20, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edis...

Volition Announces Expansion of Availability of the Nu.Q® Vet Cancer Test Through IDEXX's Reference Laboratory Network PR Newswire HENDERSON, Nev. , Jan. 12, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigene...

Volition Issues Business Review 2022 PR Newswire HENDERSON, Nev , Jan. 8, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a Business Review of 2022, outlining its key highlights as the o...